Open AccessHyperprogressive disease: a distinct effect of immunotherapy?
Author(s) -
Vinita Popat,
David E. Gerber
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.01.97
Subject(s) - medicine , gefitinib , erlotinib , kras , lung cancer , oncology , epidermal growth factor receptor , egfr inhibitors , clinical trial , malignancy , disease , immunotherapy , placebo , cancer , pathology , colorectal cancer , alternative medicine